InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-11 · accession 0000898243-25-000026 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-12 2025-12-11 IRMD HAWKINS JAMES B Dir M - OptEx — +905 29.6K +3% —
D 2025-12-12 2025-12-11 IRMD HAWKINS JAMES B Dir M - OptEx $0.00 -905 906 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-11 M A 905 — 29,647 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2025-12-11 M D 905 $0.00 906 D — · — to — 905 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.